Vertex Pharmaceuticals
VRTX
VRTX
1,540 hedge funds and large institutions have $110B invested in Vertex Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 173 funds opening new positions, 655 increasing their positions, 514 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,540
Holders Change
+54
Holders Change %
+3.63%
% of All Funds
22.4%
Holding in Top 10
33
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+10%
% of All Funds
0.48%
New
173
Increased
655
Reduced
514
Closed
90
Calls
$680M
Puts
$875M
Net Calls
-$195M
Net Calls Change
-$138M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$1.31B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$535M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$371M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$312M |
| 5 |
Goldman Sachs
New York
|
+$310M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.07B |
| 2 |
BlackRock
New York
|
-$304M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$217M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$204M |
| 5 |
ClearBridge Investments
New York
|
-$158M |
